Buy Sumitomo Chemicals: target of Rs 485: ICICI Securities

Key Investment Pillars

Diversified portfolio and access to global parent-innovator: SCIL's diversified portfolio and access to Sumitomo Chemical (SCC) and its technology are expected to drive long-term growth.
Aggressive capex and new product launches: The company's aggressive capex plans and new product launches, such as Topgrain (biostimulant) and Helibex, are expected to support growth.
Strong balance sheet and return ratios: SCIL's strong balance sheet and return ratios are expected to help the company navigate challenging market conditions.
Regulatory clearance for bio-stimulant: The company has received regulatory clearance for its bio-stimulant product, which is expected to accelerate growth in this segment.

Domestic demand recovery: A recovery in domestic demand, driven by a normalization of monsoon patterns and an improvement in agricultural productivity, would be a positive signal for the company's growth prospects.
Export performance: An improvement in export performance, driven by a recovery in global demand and the company's ability to pass on higher input costs to customers, would be a positive signal for the company's growth prospects.
Margin expansion: An expansion in margins, driven by the company's ability to maintain pricing power and control costs, would be a positive signal for the company's growth prospects.
New product launches and regulatory clearances: Successful new product launches and regulatory clearances would be a positive signal for the company's growth prospects.
Capex execution and return on investment: The successful execution of the company's capex plans and a strong return on investment would be a positive signal for the company's growth prospects.